We are using cookies to implement functions like login, shopping cart or language selection for this website. Furthermore we use Google Analytics to create anonymized statistical reports of the usage which creates Cookies too. You will find more information in our privacy policy.
OK, I agree I do not want Google Analytics-Cookies
The International Journal of Oral & Maxillofacial Implants



Forgotten password?


Int J Oral Maxillofac Implants 24 (2009), No. 1     15. Jan. 2009
Int J Oral Maxillofac Implants 24 (2009), No. 1  (15.01.2009)

Page 31-37, PubMed:19344022

The Effects of Recombinant Human Growth/Differentiation Factor-5 (RhGDF-5) on Bone Regeneration Around Titanium Dental Implants in Barrier Membrane-Protected Defects: A Pilot Study in the Mandible of Beagle Dogs
Weng, Dietmar / Poehling, Sylke / Pippig, Susanne / Bell, Matthias / Richter, Ernst-Jürgen / Zuhr, Otto / Hürzeler, Markus B.
Purpose: This dog study sought to evaluate guided bone regeneration (GBR) in peri-implant defects following implantation of b-tricalcium phosphate (b-TCP) with and without osteoinductive recombinant human growth/differentiation factor-5 (rhGDF-5).
Materials and Methods: In five beagle dogs, all mandibular premolars and the first molar were extracted. After 2 months, six buccolingual critical-size defects were created, and an implant was inserted into the center of each defect. One defect was filled with b-TCP coated with rhGDF-5 (600 µg/g b-TCP) and covered with a titanium-reinforced e-PTFE membrane (GDF group). A second defect received the same treatment, but pure uncoated b-TCP was used (TCP group). A third defect was filled with b-TCP mixed with autograft and not protected with a membrane (control group). The remaining three defects were filled with other biomaterials. After 2 months, total new bone area, regenerated bone height, and residual amount of b-TCP were determined histomorphometrically.
Results: All implants osseointegrated. One membrane in each group became exposed. Mean new bone area for GDF, TCP, and control sites was 43.9 ± 18.7 mm2, 32.3 ± 16.1 mm2, and 13.1 ± 4.0 mm2, respectively, with a significant difference between GDF and control groups. Mean regenerated bone height was 103.8 ± 29.7%, 75.4 ± 36.6%, and 67.2 ± 19.1% for the GDF, TCP, and control groups, respectively. Mean residual matrix volumes were 25.9 ± 13.6%, 30.0 ± 13.0%, and 13.4 ± 6.5%, respectively. Membrane protection of peri-implant defects filled with b-TCP resulted in a stronger effect on bone regeneration, although this was not statistically significant. The most pronounced regenerative results were achieved in rhGDF-5/b-TCP filled membrane-protected defects.
Conclusion: Delivery of rhGDF-5 on b-TCP might have the potential to enhance the results of GBR in peri-implant defects.

Keywords: autogenous bone, barrier membrane, b-tricalcium phosphate, dental implants, guided bone regeneration, recombinant human growth/differentiation factor-5